Cargando…
Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model
Dynamin 2 (DNM2) is a key protein of the endocytosis and intracellular membrane trafficking machinery. Mutations in the DNM2 gene cause autosomal dominant centronuclear myopathy (CNM) and a knock-in mouse model expressing the most frequent human DNM2 mutation in CNM (Knock In-Dnm2(R465W/+)) develops...
Autores principales: | Fongy, Anaïs, Falcone, Sestina, Lainé, Jeanne, Prudhon, Bernard, Martins-Bach, Aurea, Bitoun, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367339/ https://www.ncbi.nlm.nih.gov/pubmed/30733559 http://dx.doi.org/10.1038/s41598-018-38184-0 |
Ejemplares similares
-
Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy
por: Trochet, Delphine, et al.
Publicado: (2017) -
Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy
por: Trochet, Delphine, et al.
Publicado: (2022) -
Calcium homeostasis alterations in a mouse model of the Dynamin 2-related centronuclear myopathy
por: Fraysse, Bodvaël, et al.
Publicado: (2016) -
N-WASP is required for Amphiphysin-2/BIN1-dependent nuclear positioning and triad organization in skeletal muscle and is involved in the pathophysiology of centronuclear myopathy
por: Falcone, Sestina, et al.
Publicado: (2014) -
Dynamin-2 mutations linked to Centronuclear Myopathy impair actin-dependent trafficking in muscle cells
por: González-Jamett, Arlek M., et al.
Publicado: (2017)